Lee’s Pharm in-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

Hong Kong, December 18, 2021, the 8th General Assembly and 2021 Annual Meeting of China Pharmaceutical Industry Association was held successfully in Jiangxi building, Beijing. Yallaferon® , Interferon α2b Gel, the in-house proprietary product of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”) was honoured with “2021 Biopharmaceutical Excellent Brand” Award.

The release as fetched from its publisher. leespharm.com ↗